First steps towards price transparency: comparability of online out-of-pocket tools from Australian private health funds.
ConclusionsThese funds have started to address the need for transparent out-of-pocket cost information, but the differences across these pages demonstrate complexities and the potential obfuscation of cost data.What is known about the topic?Out-of-pocket costs are highly variable and patient 'bill shock' is an increasing concern in Australia. Private insurance funds have created online tools to share procedure cost estimates based on their claims data.What does this paper add?This is the first review of Australian insurance funds' price transparency tools. The cost information is difficult to interpret both within funds (for members) and across funds (for the system).What are the implications for practitioners?Policy makers will need to consider the complexities and presentation options for cost estimates within the health system if they move ahead with a public price transparency tool. There is still a requirement for cost information that can facilitate price shopping across providers and funders. PMID: 31715123 [PubMed - as supplied by publisher]
Condition: Chronic Pain, Acute Pain, Cotinine, Hysterectomy Intervention: Device: measuring cotinine level Sponsor: Mustafa Kemal University Recruiting
ConclusionsThe radiomics nomogram performed well for the preoperative prediction of PMI in patients with ECC and may be used as a supplementary tool to provide individualized treatment plans for patients with ECC.Key Points• No previously reported study that has utilized radiomics nomogram to preoperatively predict PMI for patients with ECC.• Radiomics model involves radiomics features extracted from joint T2WI and DWI which characterize the heterogeneity between tumors in patients with ECC.• Radiomics nomogram can assist clinicians with individualized treatment decision-making for patients with ECC.
We present the clinical case of a 34-year-old woman with a history of stage IV choriocarcinoma, after her diagnostic debut two years ago, a hysterectomy and resection of the right single pulmonary nodule with anatomopathological confirmation of both as uterine choriocarcinoma and pulmonary nodule compatible with metastatic choriocarcinoma, subsequently the patient received chemotherapy treatment with stability of her disease until now. PMID: 32054277 [PubMed - as supplied by publisher]
CONCLUSION: The authors report an unusual case of ruptured jejunal GIST with hemoperitoneum mimicking ovarian carcinoma. Therefore, GIST, in addition to ovarian cancer, should be considered in patients with an increased serum level of CA-125 and an abdominopelvic mass. PMID: 32055272 [PubMed]
Publication date: Available online 14 February 2020Source: European Journal of Obstetrics &Gynecology and Reproductive BiologyAuthor(s): Yavuz Emre Şükür, Fulya Dökmeci, Şerife Esra Çetinkaya, Mehmet Murat SevalAbstractObjectiveTo compare medium/long-term outcomes in terms of pelvic floor function, patient reported prolapse recurrence and repeat prolapse surgery after laparoscopic sacrohysteropexy (LSHP) and vaginal hysterectomy with McCall suspension (VH&McCall) which is the most commonly performed surgical option for severe uterine prolapse from past to present.Study DesignFiles of patients wh...
ConclusionsLong ‐term use of prescription opioids after hysterectomy is common and is, among other risk‐factors, strongly associated with preoperative use of opioids, as well as, psychoactive drugs and adenomyosis. To avoid opioid misuse disorders among women at risk for long‐term opioid drug prescriptions af ter hysterectomy further studies and strategies are needed.
ConclusionsPatients with squamous cell carcinoma in stage IB1 cervical cancer with tumor size ≤ 2 cm might be suitable for laparoscopic surgery, while patients with adenocarcinoma or adenosquamous carcinoma with tumor size ≤ 2 cm are not candidates for laparoscopic surgery.
Publication date: Available online 13 February 2020Source: Gynecologic Oncology ReportsAuthor(s): Amy L. Alexander, Anna E. Strohl, Kruti P. Maniar, John R. LurainAbstractPlacental site trophoblastic tumor (PSTT) is a rare variant of gestational trophoblastic neoplasia (GTN) that is characterized by slow growth resulting in mostly uterine-confined disease, low human chorionic gonadotropin (hCG) levels, and resistance to chemotherapy.Our objective was to update our center’s experience with PSTT with respect to presentation, prognostic factors, treatment, and outcomes from 2003 to 2019.Thirteen women with PSTT were ide...
Publication date: Available online 14 February 2020Source: European Journal of Obstetrics &Gynecology and Reproductive BiologyAuthor(s): Dubravko Habek, Anis Cerovac, Ana Luetić, Ingrid Marton, Matija Prka, Tomislav Kulaš, Boris UjevićAbstractObjectiveA 15-year-experience of the personal modification of Misgav Ladach (ML) caesarean section in relation to the Dörffler method.Study designA retrospective clinical randomized observational study included 822 transperitoneal cesarean sections: 557 were performed via modified ML (without bladder catheterization, small transverse fascial incision with muscular st...
ConclusionOur study did not show any impact of treatment delay on survival end-points although prolonged TTR could moderate the benefit of radiotherapy on local control rate. Surgical route was not associated with TTR, particularly robot-associated laparoscopy did not lengthen treatment delay. TTR seems dependent of health-care organization and could represent a quality criterion of EC care for institutions.